Tekmira Pharmaceuticals Corp  

(Public, NASDAQ:TKMR)   Watch this stock  
Find more results for TKMR

Officers and directors

Vivek Ramaswamy
Chairman of the Board
Mark J. Murray Ph.D.
President, Chief Executive Officer, Director
Bruce G. Cousins
Chief Financial Officer, Executive Vice President
Patrick Higgins
Chief Operating Officer
Michael J. Abrams Ph.D.
Executive Vice President and Chief Discovery Officer
Adam D. Cutler
Senior Vice President - Corporate Affairs
Mark Kowalski M.D., Ph.D.
Chief Medical Officer, Senior Vice President
Michael J. Sofia Ph.D.
Chief Scientific Officer
Bruce Dorsey
Vice President - Chemistry
Rene Cornelis Rijnbrand
Vice President - Biology


100-8900 Glenlyon Pky
+1-604-4193200 (Phone)
+1-604-4193201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company seeks to effect a cure by targeting the three pillars necessary to develop a curative regimen for HBV. This includes suppressing HBV replication within liver cells, stimulating and reactivating the body’s immune system so that it can mount an effective defense against the virus and eliminating the reservoir of viral genomic material known as covalently closed circular DNA, or cccDNA, that is the source of HBV persistence.

Related companies

* Delayed by up to 20 minutes -  Disclaimer